SCIENCEDIRECT
1. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019
Clinical Therapeutics, 8 January 2021, Volume 43, Issue 2, Pages 308-318
Yoel Benarroch, Lillian Juttukonda, Elizabeth Taglauer
https://www.sciencedirect.com/science/article/abs/pii/S0149291821000035
2. Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19
International Immunopharmacology, 9 September 2021, Volume 100, Article 108127
Mehmet Tahir HUYUT, Zübeyir HUYUT
https://www.sciencedirect.com/science/article/pii/S1567576921007633/pdfft?md5=c8ddc39dd7d6faf634935d6d36f0a23a&pid=1-s2.0-S1567576921007633-main.pdf
3. Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification
Journal of Ethnopharmacology, 22 January 2021, Volume 273, Article 113871
Shanshan Jia, Hua Luo, Wei Xiao
https://www.sciencedirect.com/science/article/pii/S0378874121000970/pdfft?md5=313faaf6ea31e14d40e8e355e98ea1dd&pid=1-s2.0-S0378874121000970-main.pdf
4. Recent progress of antiviral therapy for coronavirus disease 2019
European Journal of Pharmacology, 24 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173646
Mengmeng Zhao, Jishou Zhang, Jun Wan
https://www.sciencedirect.com/science/article/abs/pii/S001429992030738X
5. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)
International Immunopharmacology, 14 September 2021, Volume 100, Article 108137
Sajad Karampoor, Khashayar Hesamizadeh, Hossein Keyvani
https://www.sciencedirect.com/science/article/pii/S1567576921007736/pdfft?md5=2c6d493c4370c8b31c7dc194eabb5b5c&pid=1-s2.0-S1567576921007736-main.pdf
6. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
Acta Pharmaceutica Sinica B11, March 2021, Volume 11, Issue 9, Pages 2850-2858
Haiyan Yan, Jing Sun, Jiandong Jiang
https://www.sciencedirect.com/science/article/pii/S2211383521000836/pdfft?md5=51e20b3bd234ad585180bbf0c8fcf7c5&pid=1-s2.0-S2211383521000836-main.pdf
7. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial
International Immunopharmacology, 12 June 2021, Volume 98, Article 107874
Emanuela Sozio, Amato De Monte, Carlo Tascini
https://www.sciencedirect.com/science/article/pii/S1567576921005105/pdfft?md5=b88937929c0a61e4b48e342681903141&pid=1-s2.0-S1567576921005105-main.pdf
8. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
Vascular Pharmacology, 21 November 2020, Volume 137, Article 106823
Yuichiro J. Suzuki, Sofia I. Nikolaienko, Sergiy G. Gychka
https://www.sciencedirect.com/science/article/pii/S1537189120303281/pdfft?md5=51457c920072da885d6a466f6bc68f08&pid=1-s2.0-S1537189120303281-main.pdf
9. Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update
Food and Chemical Toxicology, 27 November 2020, Volume 147 (Cover date: January 2021), Article 111887
Shikha Thakur, Mayank, Gaurav Joshi
https://www.sciencedirect.com/science/article/abs/pii/S0278691520307778
10. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2
Journal of Ethnopharmacology, 24 June 2021, Volume 279, Article 114367
Qinhai Ma, Yuqi Xie, Zifeng Yang
https://www.sciencedirect.com/science/article/pii/S0378874121005961/pdfft?md5=6b26addb61db63719d042206c7c4c2f7&pid=1-s2.0-S0378874121005961-main.pdf
11. Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells
Antiviral Research, 9 August 2021, Volume 194, Article 105162
Olivier Escaffre, Alexander N. Freiberg
https://www.sciencedirect.com/science/article/pii/S0166354221001522/pdfft?md5=e54e88032d906b1052669916b0833ff7&pid=1-s2.0-S0166354221001522-main.pdf
12. COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?
Vascular Pharmacology, 22 April 2021, Volume 140, Article 106861
Vanessa Dela Justina, Fernanda R. Giachini, R. Clinton Webb
https://www.sciencedirect.com/science/article/pii/S1537189121000331/pdfft?md5=0e9ae1ec9921a7368c46ac9f346b1c49&pid=1-s2.0-S1537189121000331-main.pdf
13. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
Food and Chemical Toxicology, 25 February 2021, Volume 150, Article 112087
Shukur Wasman Smail, Muhammad Saeed, Muhammad Safdar
https://www.sciencedirect.com/science/article/abs/pii/S0278691521001204
14. The use of negative oxygen ion clusters [O2−(H2O)n] and bicarbonate ions [HCO3−] as the supportive treatment of COVID-19 infections: A possibility
Medical Hypotheses, 5 August 2021, Volume 154, Article 110658
Ravindra V. Badhe, Sonali S. Nipate
https://www.sciencedirect.com/science/article/pii/S0306987721001778/pdfft?md5=fa5a488f3c10d19a20f1437a07e53528&pid=1-s2.0-S0306987721001778-main.pdf
15. Functional and druggability analysis of the SARS-CoV-2 proteome
European Journal of Pharmacology, 1 November 2020, Volume 890, Article 173705
Claudio N. Cavasotto, Maximiliano Sánchez Lamas, Julián Maggini
https://www.sciencedirect.com/science/article/abs/pii/S0014299920307974
16. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Antiviral Research, 12 July 2021, Volume 193, Article 105137
Franck Touret, Jean-Sélim Driouich,Antoine Nougairède
https://www.sciencedirect.com/science/article/pii/S0166354221001273/pdfft?md5=4f52b79d6ecf56d28b669e3f21d3b30b&pid=1-s2.0-S0166354221001273-main.pdf
17. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
Medical Hypotheses, 6 June 2021, Volume 153, Article 110627
Amarnath Sen
https://www.sciencedirect.com/science/article/pii/S0306987721001468/pdfft?md5=fc4d13fabe196ee5263a4c84f34ffc2b&pid=1-s2.0-S0306987721001468-main.pdf
18. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19
Phytomedicine, 22 August 2020, Volume 85, Article 153310
Şevki Adem, Volkan Eyupoglu, Abdo A Elfiky
https://www.sciencedirect.com/science/article/abs/pii/S0944711320301422
19. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
Chemico-Biological Interactions, 2 December 2020, Volume 335, Article 109348
Katrina L. Forrestall, Darcy E. Burley, Sultan Darvesh
https://www.sciencedirect.com/science/article/abs/pii/S0009279720312916
20. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo
Antiviral Research, 19 June 2021, Volume 192, Article 105115
Trinayan Kashyap, Jackelyn Murray, Yosef Landesman
https://www.sciencedirect.com/science/article/pii/S0166354221001054/pdfft?md5=b4ad4e45f4e1bdfbe2e8f3e841a39f58&pid=1-s2.0-S0166354221001054-main.pdf
21. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
Pharmacological Research, 14 August 2021, Volume 172, Article 105820
Dingqi Zhang, Sami Hamdoun, Vincent Kam Wai Wong
https://www.sciencedirect.com/science/article/pii/S1043661821004047/pdfft?md5=3e16f55d2da954f09f31bb6a82a43987&pid=1-s2.0-S1043661821004047-main.pdf
22. The plausible mechanisms of tramadol for treatment of COVID-19
Medical Hypotheses, 22 December 2020, Volume 146, Article 110468
Nahla E. El-Ashmawy, Abdel-Halim A. Lashin, Mariam A. Abo-Saif
https://www.sciencedirect.com/science/article/abs/pii/S0306987720333594
23. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
European Journal of Pharmacology, 27 November 2020, Volume 891 (Cover date: 15 January 2021), Article 173759
Chaima Mouffouk, Soumia Mouffouk, Hamada Haba
https://www.sciencedirect.com/science/article/abs/pii/S0014299920308517
24. Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
International Immunopharmacology, 26 December 2020, Volume 92 (Cover date: March 2021), Article 107329
Parvaneh Baghaei, Farzaneh Dastan, Payam Tabarsi
https://www.sciencedirect.com/science/article/pii/S1567576920337966
25. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
Life Sciences, 10 December 2020, Volume 266 (Cover date: 1 February 2021), Article 118889
Jiayu Lu, Yajing Hou, Cheng Wang
https://www.sciencedirect.com/science/article/abs/pii/S0024320520316428
26. Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?
Medical Hypotheses, 4 January 2021, Volume 147, Article 110480
Niamh O'Kennedy, Asim K. Duttaroy
https://www.sciencedirect.com/science/article/pii/S0306987720333715/pdfft?md5=6f21a55f71fe7a45b4dcd61409aad252&pid=1-s2.0-S0306987720333715-main.pdf
27. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
European Journal of Pharmacology, 18 December 2020, Volume 893 (Cover date: 15 February 2021), Article 173813
Zheng Zequn, Wu Yujia, Lian Jiangfang
https://www.sciencedirect.com/science/article/pii/S0014299920309183/pdfft?md5=4e24ece784b6a2e37b2ccc1d6503e45b&pid=1-s2.0-S0014299920309183-main.pdf
28. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19
Medical Hypotheses, 7 January 2021, Volume 147, Article 110486
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
https://www.sciencedirect.com/science/article/abs/pii/S0306987721000049
29. Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
Journal of Pharmaceutical Analysis, 7 September 2020, Volume 11, Issue 3 (Cover date: June 2021), Pages 272-277
Chao Liu, Xiaoxiao Zhu, Tai Yang
https://www.sciencedirect.com/science/article/pii/S209517792031042X/pdfft?md5=02507e6f5a5d2c4cfdfe8f0de9508eff&pid=1-s2.0-S209517792031042X-main.pdf
30. SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants
Medical Hypotheses, 6 November 2020, Volume 146 (Cover date: January 2021), Article 110368
Leo Pruimboom
https://www.sciencedirect.com/science/article/abs/pii/S030698772033259X
31. Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome
International Immunopharmacology, 2 December 2020, Volume 93 (Cover date: April 2021), Article 107239
Abolghasem Allahyari, Mohsen Seddigh-Shamsi, Neda Saeedian
https://www.sciencedirect.com/science/article/pii/S1567576920337061
32. B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping
Medical Hypotheses, 6 July 2021, Volume 153, Article 110640
Kabeer Haneef, Abdul Ghaffar Memon, Mohd Sadeeq
https://www.sciencedirect.com/science/article/pii/S0306987721001596/pdfft?md5=4030a6d86d833e005742485da56ae4d6&pid=1-s2.0-S0306987721001596-main.pdf
33. Blood clots in COVID-19 patients: Simplifying the curious mystery
Medical Hypotheses, 6 November 2020, Volume 146 (Cover date: January 2021), Article 110371
Sourav Biswas, Vikram Thakur, Pradeep Kumar
https://www.sciencedirect.com/science/article/abs/pii/S030698772033262X
34. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
Antiviral Research, 8 July 2021, Volume 193, Article 105138
Esther S. Gan, Ayesa Syenina, Eng Eong Ooi
https://www.sciencedirect.com/science/article/pii/S0166354221001285/pdfft?md5=af950094a4e35824a0d5a255b5bb77e3&pid=1-s2.0-S0166354221001285-main.pdf
35. Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity
Food and Chemical Toxicology, 23 January 2021, Volume 149, Article 112007
Prem Rajak, Abhratanu Ganguly, Sumedha Roy
https://www.sciencedirect.com/science/article/abs/pii/S0278691521000417
36. Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
Current Research in Pharmacology and Drug Discovery, 12 August 2021, Volume 2, Article 100045
Sijia TaoKeivan Zandi, Raymond F. Schinazi
https://www.sciencedirect.com/science/article/pii/S2590257121000328/pdfft?md5=af8a166bb80caa6d71cd1d59c0c7f35f&pid=1-s2.0-S2590257121000328-main.pdf
37. Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study
Medical Hypotheses, 9 August 2021, Volume 155, Article 110656
Ki Kwang Oh, Md. Adnan, Dong Ha Cho
https://www.sciencedirect.com/science/article/pii/S0306987721001754/pdfft?md5=56af13b577af5fdb97d5d0540ae386dc&pid=1-s2.0-S0306987721001754-main.pdf
38. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
European Journal of Pharmacology, 17 May 2021, Volume 904, Article 174193
Abdolkarim Hosseini, Hadi Esmaeili Gouvarchin Ghaleh, Gholamreza
https://www.sciencedirect.com/science/article/abs/pii/S0014299921003460
39. Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
European Journal of Pharmacology, 23 January 2021, Volume 896, Article 173897
Shuai Ge, Xiangjun Wang, Huaizhen He
https://www.sciencedirect.com/science/article/abs/pii/S0014299921000509
40. Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
European Journal of Pharmacology, 3 November 2020, Volume 890 (Cover date: 5 January 2021), Article 173717
Harmanjit Singh, Prerna Chauhan, Ashish Kumar Kakkar
https://www.sciencedirect.com/science/article/abs/pii/S0014299920308098
41. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
Medical Hypotheses, 5 January 2021, Volume 147, Article 110479
Ciro Manzo, Jordi Serra-Mestres, Alberto Castagna
https://www.sciencedirect.com/science/article/abs/pii/S0306987720333703
42. In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
European Journal of Pharmacology, 29 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173701
Nouredine Behloul, Sarra Baha, Jihong Meng
https://www.sciencedirect.com/science/article/abs/pii/S0014299920307937
43. Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
Biomedicine & Pharmacotherapy, 13 September 2021, Volume 143, Article 112159
Riffat Mehboob
https://www.sciencedirect.com/science/article/pii/S0753332221009434/pdfft?md5=b28d15ca1a7b83a8e9d17eefedd040ac&pid=1-s2.0-S0753332221009434-main.pdf
44. Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection
International Journal of Pharmaceutics, 18 August 2021, Volume 607, Article 121023
Shaymaa Elsayed Khater, Ahmed El-khouly, Dalia Mahmoud Ghorab
https://www.sciencedirect.com/science/article/pii/S0378517321008292/pdfft?md5=a9c64d2cde81c20b1c2d1b3841b2a249&pid=1-s2.0-S0378517321008292-main.pdf
45. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage
Toxicology Reports, 8 July 2021, Volume 8, Pages 1394-1398
Athanasios ChalkiasIoannis Pantazopoulos, Eleni Arnaoutoglou
https://www.sciencedirect.com/science/article/pii/S2214750021001311/pdfft?md5=9f71752fb1ac76609fdb2571e1b35aa5&pid=1-s2.0-S2214750021001311-main.pdf
46. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients
International Immunopharmacology, 9 September 2021, Volume 100, Article 108125
Paula C. Teixeira, Gilson P. Dorneles, Pedro R. T. Romão
https://www.sciencedirect.com/science/article/pii/S156757692100761X/pdfft?md5=9e9624a0e628606ac70bdfc67504de9e&pid=1-s2.0-S156757692100761X-main.pdf
47. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors
European Journal of Medicinal Chemistry, 18 August 2021, Volume 225, Article 113789
Jiahua Cui, Jinping Jia
https://www.sciencedirect.com/science/article/pii/S0223523421006383/pdfft?md5=755a8a132586993c2125ae586a739e91&pid=1-s2.0-S0223523421006383-main.pdf
48. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target
Antiviral Research, 24 August 2021, Volume 194, Article 105167
Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Covadonga Alonso
https://www.sciencedirect.com/science/article/pii/S0166354221001571/pdfft?md5=0c4ffe6f78c183c8081f848db4d220c9&pid=1-s2.0-S0166354221001571-main.pdf
49. Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
Biomedicine & Pharmacotherapy, 3 February 2021, Volume 137, Article 111356
Akalesh Kumar Verma, Vikas Kumar, Keun Woo Lee
https://www.sciencedirect.com/science/article/pii/S0753332221001414/pdfft?md5=c32bdd8691f42ed20ed1b51538aa0798&pid=1-s2.0-S0753332221001414-main.pdf
50. Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies
European Journal of Pharmacology, 29 October 2020, Volume 890 (Cover date: 5 January 2021), Article 173688
Pooja M, Gangavaram Jyothi Reddy, Bharathi Koganti
https://www.sciencedirect.com/science/article/abs/pii/S0014299920307809
51. Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19
European Journal of Pharmacology, 6 November 2020, Volume 890, Article 173720
Himanshu G. Toor, Devjani I. Banerjee, Siddhi A. Darji
https://www.sciencedirect.com/science/article/abs/pii/S0014299920308128
52. Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis
Phytomedicine, 8 August 2021, Volume 91, Article 153704
Ting Xiao, Yuli Wei, Honggang Zhou
https://www.sciencedirect.com/science/article/pii/S0944711321002476/pdfft?md5=602f6fce37a45dd21628a83ae43868aa&pid=1-s2.0-S0944711321002476-main.pdf
53. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
Medical Hypotheses, 12 November 2020, Volume 146 (Cover date: January 2021), Article 110394
Xiyuan Bai, Joseph Hippensteel, Edward D. Chan
https://www.sciencedirect.com/science/article/pii/S0306987720332850/pdfft?md5=5ffb9a5cf46383a849d3fecade729200&pid=1-s2.0-S0306987720332850-main.pdf
54. Crystal structure of SARS-CoV-2 papain-like protease
Acta Pharmaceutica Sinica B2, September 2020, Volume 11, Issue 1 (Cover date: January 2021), Pages 237-245
Xiaopan Gao, Bo Qin, Sheng Cui
https://www.sciencedirect.com/science/article/pii/S2211383520306985/pdfft?md5=587371801e0d971b494a5c5fed1d4da4&pid=1-s2.0-S2211383520306985-main.pdf
55. Rapid detection of SARS-CoV-2 using a radiolabeled antibody
Nuclear Medicine and Biology, 25 May 2021, Volumes 98–99, Pages 69-75
Giacomo Pirovano, Alvaro A. Ordonez, Naga Vara Kishore Pillarsetty
https://www.sciencedirect.com/science/article/abs/pii/S0969805121004686
56. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial
International Immunopharmacology, 29 June 2021, Volume 99, Article 107916
Ilad Alavi Darazam, Firouze Hatami, Navid Shafigh
https://www.sciencedirect.com/science/article/pii/S156757692100552X/pdfft?md5=8314e10debf50df6d6d2d331c0c4428e&pid=1-s2.0-S156757692100552X-main.pdf
57. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients
International Immunopharmacology, 23 July 2021, Volume 99, Article 107998
Payam Tabarsi, Seyed Mohammad Reza Hashemian, Farzaneh Dastan
https://www.sciencedirect.com/science/article/pii/S1567576921006342/pdfft?md5=afc048b6449413638688772a846e3c3c&pid=1-s2.0-S1567576921006342-main.pdf
58. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase
Antiviral Research, 21 April 2021, Volume 190, Article 105078
Jianyuan Zhao, SaiSai Guo, Shan Cen
https://www.sciencedirect.com/science/article/pii/S0166354221000681/pdfft?md5=028d7dc7deae86277578ffefc8b21c42&pid=1-s2.0-S0166354221000681-main.pdf
59. Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
Biomedicine & Pharmacotherapy, 20 March 2021, Volume 138, Article 111526
Marcelo Augusto Duarte Silveira, David De Jong, Rogerio da Hora Passos
https://www.sciencedirect.com/science/article/pii/S0753332221003115/pdfft?md5=5e6d29579abd9c434478bf292c9c12fb&pid=1-s2.0-S0753332221003115-main.pdf
60. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CEuropean Journal of Pharmacology, 3 April 2021, Volume 901, Article 174082
Dhananjay Jade, Selvaraj Ayyamperumal, Moola Joghee NanjanLPRO proteases
https://www.sciencedirect.com/science/article/abs/pii/S0014299921002351
WILEY:
1. Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
Arighna Sarkar, Kalyaneswar Mandal
Angewandte Chemie International Edition
First published: 21 September 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/anie.202107481
2. Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola
Cruz S. Sebastião, Celestina Gaston, Joana Paula Paixão, Euclides N.M. Sacomboio, Zoraima Neto, Jocelyne Neto de Vasconcelos, Joana Morais
Journal of Medical Virology
First published: 21 September 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27354
3. Metal complexes of Tridentate Schiff base: Synthesis, Characterization, Biological Activity and Molecular Docking Studies with COVID-19 Protein Receptor
Gehad Genidy mohamed, Mohamed Mohamed Omar, yasmin mamdoh hussien ahmed
Zeitschrift für anorganische und allgemeine Chemie
First published: 21 September 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/zaac.202100245
4. Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection
Matthew J. Blitz, Rachel P. Gerber, Moti Gulersen, Weiwei Shan, Andrew C. Rausch, Lakha Prasannan, Natalie Meirowitz, Burton Rochelson
Acta Obstetricia et Gynecologica Scandinavica
First published: 21 September 2021
https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1111/aogs.14269
5. Antibody Screening at Reduced pH Enables Preferential Selection of Potently Neutralizing Antibodies Targeting SARS-CoV-2
Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira de Souza, Bailey B. Banach, Sheila N. López Acevedo, Xiaoli Pan, Rajani Nimrania, I-Ting Teng, Fabiana Bahna, Tongqing Zhou, Baoshan Zhang, Michael T. Yin, David D. Ho, Peter D. Kwong, Lawrence Shapiro, Brandon J. DeKosky
AIChE Journal
First published: 20 September 2021
https://aiche.onlinelibrary.wiley.com/doi/epdf/10.1002/aic.17440
6. On the weak binding and spectroscopic signature of SARS-CoV-2 nsp14 interaction with RNA
Ayaz Hassan, Graziela C Sedenho, Phelipe A. M. Vitale, Mona N Oliveira, Frank Nelson Crespilho
ChemBioChem
First published: 20 September 2021
https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cbic.202100486
7. COMPARISON OF PULSE-DOSE AND HIGH-DOSE CORTICOSTEROIDS WITH NO CORTICOSTEROID TREATMENT FOR COVID-19 PNEUMONIA IN THE INTENSIVE CARE UNIT
Hamid Yaqoob MD, Daniel Greenberg DO, Frank Hwang BS, Curtis Lee BA, David Vernik MBA, Ravi Manglani MD, Zhen Wang PhD, M. Hassan Murad MD, Dipak Chandy MD, Oleg Epelbaum MD
Journal of Medical Virology
First published: 20 September 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27351
8. Using Different Machine Learning Models to Classify Patients with Mild and Severe Cases of COVID-19 Based on Multivariate Blood Testing
Rui-kun Zhang, Qi Xiao, Sheng-lang Zhu, Hai-yan Lin, Ming Tang
Journal of Medical Virology
First published: 20 September 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27352
SPRINGER NATURE
1. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study
Qing-Lei Zeng, Zu-Jiang Yu, Fanpu Ji, Guang-Ming Li… in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06572-z.pdf
2. Clinical Outcomes of Patients Hospitalized with Coronavirus Disease 2019 (COVID-19) in Boston
Areej El-Jawahri MD, Hacho B. Bohossian MD… in Journal of General Internal Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11606-021-06622-x.pdf
3. A cluster randomized trial of interferon ß-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19)
Carolina Iturriaga, Nat Eiffler, Rad Aniba, Rym Ben-Othman… in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06519-4.pdf
4. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
Yuqing Cui, Yali Sun, Junyi Sun, Huoyan Liang… in Infectious Diseases and Therapy (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40121-021-00518-3.pdf
5. The repurposed use of anesthesia machines to ventilate critically ill patients with coronavirus disease 2019 (COVID-19)
Maurizio Bottiroli, Angelo Calini, Riccardo Pinciroli, Ariel Mueller… in BMC Anesthesiology (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12871-021-01376-9.pdf
6. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study
Tak Kyu Oh, In-Ae Song in BMC Pulmonary Medicine (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12890-020-01387-1.pdf
7. Clinical value of blood markers to assess the severity of coronavirus disease 2019
Liu-Niu Xiao, Xiao Ran, Yan-Xia Zhong, Shu-Sheng Li in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06623-5.pdf
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 10/09 đến ngày 17/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-9-den-ngay-17-9-2021-4002.html
Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html
Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html
Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html
Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html
Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html
Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html
Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html
Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html
Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html
Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html
Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html
Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html
Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html
Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html
Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html
Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html
Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html
Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html
Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html
Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html
Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html
Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html
Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html
Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html
Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html
Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html
Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html
Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html
Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html
Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html
Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html
Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html
Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html
Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html
Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html
Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html
Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html
Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html
Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html
Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html
Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html
Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html
Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html
Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html
Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020
https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html
Cập nhật các công bố về COVID-19 đến ngày 07/6/2020
http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html
Cập nhật các công bố về COVID-19 đến ngày 01/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html
Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html
Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html
Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html
Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html
Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020
https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020
https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020
https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020
https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020
https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020
https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020
https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN
Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx
Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx